There are lots of new opportunities in ablation, evidenced by the research touted at this year’s annual meeting of the Heart Rhythm Society in Boston. Scientists presented data from trials evaluating cardiac ablation via pulsed electric fields, intramural needle ablation and more. Editors at MassDevice.com asked leading cardiac electrophysiologist Dr. Vivek Reddy, will there someday be one […]
Medtronic
HRS 2018 Roundup: Device-related blood clots with Boston Scientific’s Watchman implant
Data from a study of device-related blood clots and the Watchman cardiac implant made by Boston Scientific (NYSE:BSX), presented today at the annual meeting of the Heart Rhythm Society in Boston, indicate the need for aggressive management of patients at risk for device-related thrombosis. There were 74 incidences of DRT in 65 of the 1,739 Watchman […]
Medtronic touts Micra leadless pacer post-approval registry study data
Medtronic (NYSE:MDT) today released one-year results from the post-approval registry study of its Micra leadless transcatheter pacing system, touting a high implant success rate and a low complication rate. Results from the study are slated to be presented tomorrow at the Heart Rhythm Society’s annual scientific sessions conference in Boston, the Fridley, Minn.-based company said. Medtronic’s Micra […]
Medtronic initiates select recall of Covidien Endo GIA staplers
Medtronic (NYSE:MDT) this month issued a select recall for specific Covidien Endo GIA staplers over possible missing components, according to a safety field notice from the company. The Fridley, Minn.-based company warned that the Endo GIA articulating loading units could possibly be missing a sled component designed for staple deployment, making it unable to deploy staples. […]
Medtronic deals stake in China’s LifeTech Scientific
Medtronic (NYSE:MDT) last week dealt its stake in LifeTech Scientific (HK:8122) to China Everbright Ltd. (HK:0165) and another unnamed investor. In October 2012 Medtronic picked up a roughly 26% interest in LifeTech, acquiring a 19% equity stake for $46.6 million and another 7% in a $19.6 million convertible note purchase. The agreement called for LifeTech to develop a line […]
Medtronic taps former JP Morgan analyst Weinstein for strategy SVP | Personnel Moves – May 7, 2018
Medtronic (NYSE:MDT) said today it tapped former J.P. Morgan Chase & Co. analyst Mike Weinstein as its strategy senior VP. Prior to joining Medtronic, Weinstein served as a managing director for JP Morgan’s equity research healthcare team, holding positions within the unit for more than 20 years, the Fridley, Minn.-based company said. “We are excited to […]
Medtronic launches Synergy TLIF lumbar spine surgery workflow
Medtronic (NYSE:MDT) said today it launched the Synergy TLIF workflow procedural solution for navigated minimally invasive lumbar spine surgery. The newly launched SynergyTLIF system combines the company’s O-arm system imaging and StealthStation imaging guidance, the Fridley, Minn.-based company said. “This new workflow is another example of how our portfolio breadth enables us to transform spine outcomes for […]
Medtronic expands paid family leave benefits for US employees | Personnel Moves – May 1, 2018
Medtronic (NYSE:MDT) today announced expanded paid family leave benefits which the company says will “allow for greater employee flexibility while balancing work and family priorities.” The new benefits, which went into effect today, cover full and part-time US employees and allow for a “wide range of family care leave needs,” the Fridley, Minn.-based company said. These […]
Medtronic wins FDA PMA for DBS epilepsy treatment
Medtronic (NYSE:MDT) said today it won FDA premarket approval for its Deep Brain Stimulation therapy, indicated as an adjunctive treatment for reducing the frequency of partial-onset seizures. The DBS treatment is cleared for patients 18 years or older who are refractory or drug resistant to three or more antiepileptic medications, the Fridley, Minn.-based company said. Medtronic’s […]
Medtronic wins expanded indications for Infuse bone growth protein
Medtronic (NYSE:MDT) said today it won expanded approval from the FDA for its Infuse bone growth protein implant, marking the second expansion for the implant over the past two years. The Infuse implant contains the active ingredient rhBMP-2, a manufactured version of a bone growth protein normally present in the body. The Infuse device is […]
Medtronic dropped from Infuse trial, implanting doc acquitted by jury
A surgeon who used one of Medtronic‘s (NYSE:MDT) controversial InFuse bone-growth protein spinal implants in an “off-label” lumbar procedure has been acquitted by a California state jury, after Medtronic had already been dropped from the case as a defendant, according to the Courtroom View Network. The surgeon, Dr. William Dobkin, was found not negligent in […]